文献速递认知障碍与痴呆

精神科共病与多发性硬化残疾进展相关

Psychiatric comorbidity is associated with disability progression in multiple sclerosis.
PubMed 文献 · Neurology · 2018-03-09

这项回顾性队列研究利用加拿大不列颠哥伦比亚省和新斯科舍省关联的临床与人口健康行政数据库,纳入2312例成人起病多发性硬化患者,平均随访10.5年,其中35.8%符合情绪或焦虑障碍标准。情绪或焦虑障碍的存在与更高的扩展残疾状态量表评分相关(β系数=0.28,p=0.0002),该关联在女性中具有统计学显著性(β系数=0.31,p=0.0004),在男性中未达统计学显著(β系数=0.22,p=0.17)。作者认为优化精神科共病管理应作为可能减轻多发性硬化残疾进展的手段加以探索。

要点

  • 情绪或焦虑障碍在多发性硬化发病队列中常见,占35.8%。
  • 情绪或焦虑障碍与更高的EDSS评分相关(β系数=0.28,p=0.0002)。
  • 该关联在女性中显著(β系数=0.31,p=0.0004),男性中未达显著(β系数=0.22,p=0.17)。

核心结论

  • 精神科共病在本发病多发性硬化队列中常见,并增加后续神经残疾的严重程度。
  • 作者建议探索优化精神科共病管理作为可能减轻多发性硬化残疾进展的手段。

研究设计与样本

  • 回顾性队列研究,利用加拿大不列颠哥伦比亚省和新斯科舍省关联的临床与人口健康行政数据库前瞻性收集的信息。
  • 采用经过验证的算法通过医生和医院就诊记录识别患有抑郁、焦虑或双相障碍的多发性硬化患者。
  • 纳入2312例成人起病多发性硬化发病病例,平均随访10.5年;使用广义估计方程以恒等链接拟合多变量线性回归模型,分析精神科共病与所有可用扩展残疾状态量表(EDSS)评分之间的关联。

主要发现

  • 随访期间35.8%的患者符合情绪或焦虑障碍标准。
  • 情绪或焦虑障碍的存在与更高的EDSS评分相关(β系数=0.28,p=0.0002,校正病程与临床分型、年龄、性别、社会经济状况、躯体共病数量及疾病修饰治疗暴露)。
  • 该关联在女性中具有统计学显著性(β系数=0.31,p=0.0004),在男性中未达统计学显著(β系数=0.22,p=0.17)。

临床怎么用

  • 作者认为优化精神科共病管理应作为可能减轻多发性硬化残疾进展的手段加以探索。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Emerging evidence suggests that comorbidity may influence disability outcomes in multiple sclerosis (MS); we investigated the association between psychiatric comorbidity and MS disability progression in a large multiclinic population. METHODS: This retrospective cohort study accessed prospectively collected information from linked clinical and population-based health administrative databases in the Canadian provinces of British Columbia and Nova Scotia. Persons with MS who had depression, anxiety, or bipolar disorder were identified using validated algorithms using physician and hospital visits. Multivariable linear regression models fitted using an identity link with generalized estimating equations were used to determine the association between psychiatric comorbidity and disability using all available Expanded Disability Status Scale (EDSS) scores. RESULTS: A total of 2,312 incident cases of adult-onset MS were followed for a mean of 10.5 years, during which time 35.8% met criteria for a mood or anxiety disorder. The presence of a mood or anxiety disorder was associated with a higher EDSS score (β coefficient = 0.28, p = 0.0002, adjusted for disease duration and course, age, sex, socioeconomic status, physical comorbidity count, and disease-modifying therapy exposure). Findings were statistically significant among women (β coefficient = 0.31, p = 0.0004), but not men (β coefficient 0.22, p = 0.17). CONCLUSION: Presence of psychiatric comorbidities, which were common in our incident MS cohort, increased the severity of subsequent neurologic disability. Optimizing management of psychiatric comorbidities should be explored as a means of potentially mitigating disability progression in MS.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. McKay KA, Tremlett H, Fisk JD, et al. Psychiatric comorbidity is associated with disability progression in multiple sclerosis. Neurology. 2018. PMID: 29523642. doi:10.1212/WNL.0000000000005302

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。